51517-04-5

Usage

Uses

Used in Pharmaceutical Industry:
2-Methoxyethane-1-sulfonaMide is used as a detoxifying agent for the treatment of chemotherapy-induced hemorrhagic cystitis and paracetamol overdoses. It works by binding to and inactivating toxic metabolites of chemotherapy drugs, such as ifosfamide, and preventing damage to the bladder wall.
Used in Medical Industry:
2-Methoxyethane-1-sulfonaMide is used as a mucolytic agent and is sometimes used as a stabilizer for certain medications. It is administered intravenously or orally and is generally well tolerated with minimal side effects.

Upstream product

• 51517-01-2 2-methoxyethane-1-sulfonyl chloride 

Downstream Products

• 1162669-67-1 (2'S,3S,4'R)-6-chloro-4'-{5-chloro-2-[2-(2-methoxy-ethanesulfonylamino)-1,1-dimethyl-2-oxo-ethoxy]-phenyl}-2'-(5-fluoro-2-methyl-phenyl)-spiro[3H-indole-3,3'-piperidine]-2,6'(1H)-dione 
• 2386-58-5 vinyl sulfonamide 

Relevant academic research and scientific papers

THIAZOLIDINONE COMPOUNDS AND USE THEREOF

A pharmaceutical composition containing a compound of Formula (I) for treating an opioid receptor-associated condition. Also disclosed is a method for treating an opioid receptor-associated condition using such a compound. Further disclosed are two sets of thiazolidinone compounds of formula (I): (i) compounds each having an enantiomeric excess greater than 90% and (ii) compounds each being substituted with deuterium.

NITROGENATED HETEROCYCLIC COMPOUND

A nitrogen-containing heterocyclic compound represented by formula (I-A): (wherein R1A represents lower alkyl which may be substituted with lower alkoxy, R3A represents lower alkyl substituted with fluorine atom(s), and RqA represents an optionally substituted aromatic heterocyclic group) or the like, or a pharmaceutically acceptable salt thereof; and the like, are provided.

NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING INHIBITORY EFFECT ON PRODUCTION OF KYNURENINE

The present invention provides a nitrogen-containing heterocyclic compound or a pharmaceutically acceptable salt thereof having an inhibitory effect on the production of kynurenine, represented by formula (I): (wherein R6 and R7 may be the same or different and each represent a hydrogen atom or the like, R8, R9, R19, and R11 may be the same or different and each represent a hydrogen atom or the like, R1 represents lower alkyl which may be substituted with cycloalkyl, or the like, and R3 represents optionally substituted aryl or an optionally substituted heterocyclic group).

N - ( 2 - aryl - propionyl ) - sulfonamides and pharmaceutical preparations containing them

The compounds of formula 1, wherein R and R2 are as defined in the disclosure, are useful in the prevention and treatment of tissue damage due to exacerbated recruitment of polymorphonuclear neutrophils (PMN leukocytes) at the inflammatory sites.